We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Pharmaceutical and healthcare companies around the world rely on the expertise of West's contract manufacturing team—formerly known as The Tech Group to create innovative, safe and effective drug delivery systems that bring important therapies to patients. For those companies – like ours – quality and innovation are of the utmost importance.
In part one of our video series West on the Road – Tempe, we look at how West's contract manufacturing Rockford campus in Tempe, Arizona is developing advanced automation systems and programs to ensure the quality and efficacy of drug delivery and monitoring systems. This begins by establishing manufacturing processes based on a deep understanding of the customer’s needs and the products themselves. West's contract manufacturing engineers at the 96,500-square-foot facility learn our customer’s products inside and out. They combine that insight with their deep knowledge of medical devices and materials, such as plastics, as well as the latest in insert and multi-shot molding techniques to ensure we’re meeting the needs of our pharmaceutical partners and the patients relying on them.
While the medical manufacturing industry today may be complex as ever, Director of Operations, Mike Moran, believes that manufacturing processes will only grow in complexity in the coming years as a changing healthcare environment—one that is ever more patient-centric—will continue to demand more of the pharmaceutical industry and their manufacturing partners.
Ultimately, people at the contract manufacturing plant understand the critical role that they play in bringing drug delivery systems from concept to patient and delivering the high quality that our pharmaceutical customers – and patients – demand.
West is committed to the safe and efficient delivery of drug products to patients. An important aspect of this commitment is engagement in standards-setting organizations; West is a member of the European Pharmacopoeia Commission, Group of Experts 16 – who contributed to European Pharmacopoeia 9.5 (effective July 2018).<br /><div> </div>
With the growth of gene and cell therapies, there is an increased need to characterize container closure systems (CCS) at the low temperatures experienced during their lifecycles: ultra-low (-80°C) for genes and cryogenic (-180°C) for cells. West’s Integrated Solutions platform includes the state-of-the-art container closure integrity (CCI) capabilities needed for these therapies.
Recently, there has been increased scrutiny from regulatory authorities to quantify and qualify subvisible particles in biopharmaceutical products. Such particles, which can cause a protein to denature, are of concern to pharmaceutical manufacturers since they can affect the efficacy of the drug product. As regulatory bodies continue to raise the bar on quality, industry is looking for “zero defect” and particle free components as well as a way to minimize quality variation.
Celebrating its 30th anniversary, Canine Partners for Life (CPL) has been dedicated to training service dogs, home companion dogs, residential companion dogs, and courthouse companion dogs to assist individuals who have a wide range of physical, neurological, and cognitive disabilities.
The market for prefillable syringe systems (PFS) is growing at a rate of approximately 10 percent per year, with cartridge-based systems growing even faster at rates of 13 percent (2013 market outlook, IMS). The predominant areas of growth are within the insulin and biologics therapeutic areas, as well as overall growth within emerging markets.
English
Chinese
